Demo the EyeBOX
The first and fastest objective FDA cleared aid in the diagnosis of concussion at AMSSM 2022
April 8 – April 13, 2022
Austin Convention Center
Austin Convention Center
Meet Our Team at Booth #303.
FDA Cleared
EyeBOX is the first and only baseline-free device with FDA clearance to diagnose mild traumatic brain injury (mTBI), also known as concussion within seven days of injury.
Clinically Validated
EyeBOX technology has been subject of 11 publications with more in progress.
Provides Objective Measurement
Instead of relying on subjective patient-reported symptoms. EyeBOX objectively aids in diagnosing concussions based on cranial nerve function.
Wide Patient Range
Ability to assess patients from ages 5 to 67.
Join us at AMSSM22 to meet Oculogica’s team and learn how EyeBOX’s technology can support your practice.
Move beyond “follow my finger” with EyeBOX’s breakthrough technology-driven solution to diagnose concussion accurately.